Clinicians should have a standard approach for discussing the risk of adverse events associated with immune checkpoint inhibitors, researchers say.

Of the studies on psychosocial wellbeing in patients with melanoma in situ, no differences were observed when compared with melanoma in higher stages.

(Alliance News) - Scancell Holdings PLC on Monday reported positive data from an ongoing trial on patients receiving a treatment combination for advanced melanoma, a skin cancer.

Melanoma is a type of skin cancer that often appears as ... Several factors affect cancer survival rates, including: Early detection is an important part of cancer treatment. In most cases, the ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

The NHS DigiTrials initiative is supporting three major cancer projects, which will aim to recruit tens of thousands of ...

By Page Leggett Cale Banks makes it a practice to get to work early. The assistant nurse manager for the operating rooms at ...

"It's incredible, and a big surprise, that the same infection that caused so much devastation can help create a ...

Immune cells produced during severe COVID-19 infection may shrink tumors. The unexpected mechanism offers a new therapeutic ...

Former winner of TV show Alone Australia Gina Chick was diagnosed with breast cancer just days after finding out she was ...

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a ...

The advantages and disadvantages of CAR-T cell therapy should be carefully thought about for patients with melanoma.